Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Melnick, MD
Spero Therapeutics Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
96 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical Facility
Blagoevgrad, Bulgaria
- Medical Facility
Dobrich, Bulgaria
- Medical Facility
Rousse, Bulgaria
- Medical Facility
Shumen, Bulgaria
- Medical Facility
Sofia, Bulgaria
- Medical Facility
Sofia, Bulgaria
- Medical Facility
Veliko Tarnovo, Bulgaria
- Medical Facility
Karlovy Vary, Czechia
- Medical Facility
Liberec, Czechia
- Medical Facility
Prague, Czechia
- Medical Facility
Zlín, Czechia
- Medical Facility
Ústí nad Labem, Czechia
- Medical Facility
Kohtla-Järve, Estonia
- Medical Facility
Tallinn, Estonia
- Medical Facility
Võru, Estonia
- Medical Facility
Tbilisi, Georgia
- Medical Facility
Tbilisi, Georgia
- Medical Facility
Tbilisi, Georgia
- Medical Facility
Tbilisi, Georgia
- Medical Facility
Zestaponi, Georgia
- Medical Facility
Budapest, Hungary
- Medical Facility
Budapest, Hungary
- Medical Facility
Nagykanizsa, Hungary
- Medical Facility
Nyíregyháza, Hungary
- Medical Facility
Tatabánya, Hungary
- Medical Facility
Riga, Latvia
- Medical Facility
Riga, Latvia
- Medical Facility
Valmiera, Latvia
- Medical Facility
Chisinau, Moldova
- Medical Facility
Chisinau, Moldova
- Medical Facility
Katowice, Poland
- Medical Facility
Krakow, Poland
- Medical Facility
Lodz, Poland
- Medical Facility
Oświęcim, Poland
- Medical Facility
Wroclaw, Poland
- Medical Facility
Bucharest, Romania
- Medical Facility
Bucharest, Romania
- Medical Facility
Bucharest, Romania
- Medical Facility
Craiova, Romania
- Medical Facility
Iași, Romania
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2019
- Primary completion
- 20 May 2020
- Completion
- 27 May 2020
- Last update posted
- 25 Jul 2022
- Registered enrollment
- 1,372
- Registry id
- NCT03788967
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.